Using ovarian and breast cancer models, Barkal et al. identify CD24 as a novel anti-phagocytic ‘don’t eat me’ signal on tumour-associated macrophages that orchestrates an innate immune checkpoint to modulate antitumour immunity, highlighting the promise of CD24 blockade as an immunotherapy strategy.